The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy

被引：0
|
作者：
Ono, Ryohei
Fukushima, Kenichi
Takahashi, Hidehisa R.
Hori, Yasuhiko
Kobayashi, Yoshio
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15194
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336
  • [2] Distribution of Anti-Factor Xa Activity Value, Prothrombin Time, and Activated Partial Thromboplastin Time in Patients Treated With Factor Xa Inhibitors
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. CIRCULATION, 2022, 146
  • [3] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
  • [4] CORRELATION OF ANTI-FACTOR XA ACTIVITY VALUE, PROTHROMBIN TIME, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH FACTOR XA INHIBITORS
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2109 - 2109
  • [5] THE CORRELATIONS BETWEEN ANTI-FACTOR XA ACTIVITY VALUES AND PROTHROMBIN TIME/ACTIVATED PARTIAL THROMBOPLASTIN TIME AT PEAK AND TROUGH TIMES IN PATIENTS ON DIRECT ORAL ANTICOAGULANTS THERAPY
    Ono, Ryohei
    Fukushima, Kenichi
    Yamashita, Daichi
    Takahashi, Hidehisa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2107 - 2107
  • [6] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [7] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    [J]. THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
  • [8] Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms
    Whitman-Purves, Emily
    Coons, James C.
    Miller, Taylor
    DiNella, Jeannine V.
    Althouse, Andrew
    Schmidhofer, Mark
    Smith, Roy E.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (02) : 310 - 316
  • [9] IMPROVING CLINICAL DECISION MAKING FOR HEPARINIZED PATIENTS WITH DISCORDANT ANTI-FACTOR XA ACTIVITY AND ACTIVATED PARTIAL THROMBOPLASTIN TIME.
    Gombar, Saurabh
    Krishnan, Anandi
    Zehnder, James
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 40 - 40
  • [10] Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
    Adatya, Sirtaz
    Uriel, Nir
    Yarmohammadi, Hirad
    Holley, Christopher T.
    Feng, Amy
    Roy, Samit S.
    Reding, Mark T.
    John, Ranjit
    Eckman, Peter
    Zantek, Nicole D.
    [J]. JACC-HEART FAILURE, 2015, 3 (04) : 314 - 322
12345